Recent reports have pointed out the difficulties in generating recombinant adenoviral vectors expressing FasL using eukaryotic cells. In the present study we cloned the murine FasL (mFasL) gene into the pCA14 or pShuttle vectors and recombined them with the adeno-5 virus backbone pBHG10 or pAdEasy-1 in eukaryotic (911 cells) or prokaryotic (E. coli) cells, respectively. Recombination of pCA14-mFasL with pBHG10 in Fas-carrying 911 cells leads to rapid expression of mFasL and cell death by apoptosis before virus replication is initiated. The same effect is observed when 911 cells are transfected with the pCA14-mFasL shuttle vector only. If
The Fas ligand (FasL) belongs to the tumor necrosis factor (TNF) family, which includes TNF, lymphotoxin, TRAIL (TNF-related apoptosis-inducing ligand), CD40 ligand, CD27 ligand, CD30 ligand and OX40 ligand. 1 FasL induces apoptosis resulting in the death of cells expressing the Fas receptor (APO-1, CD95). Whereas FasL is predominantly found in activated T cells and natural killer cells, [2] [3] [4] its receptor is expressed in many other cell types. [5] [6] [7] The Fas/FasL system is involved in the regulation of the immune response and contributes to the functional barrier which abrogates cytotoxic lymphocyte aggression in immune-privileged sites. 8 Its role in immunoregulation is mainly attributable to the induction of tolerance to autoantigens, down-regulation of lymphocyte expansion via cell-cell interaction, and the reduction of excess active lymphocytes following an immune response. 9 As shown by the experiments of Bellgrau et al 10 the expression of FasL in the Sertoli cells of testis is responsible for apoptosis of Fas-expressing T cells and thus may contribute to the immune-privileged environment provided by this organ. It is also thought that FasL plays a pivotal role in creating an immune-privileged site in the anterior eye chamber. 8 In the present work we describe a novel way to generate successfully mFasL gene-harbouring E1-deleted adenovirus type 5 in apoptosis-sensitive eukaryotic cells.
In a first series of experiments we used the adenovirus-5 system developed by Graham's group, 18 ,19 comprising a shuttle plasmid (eg pCA14) and an adenovirus-5 plasmid (eg pBHG10) for recombination in permissive 293 or 911 cells. The mFasL gene was cloned into the pCA14 shuttle plasmid which contains the human cytomegalovirus immediate-early promoter (CMV). 20 911 Cells, a human embryonic retinoblast cell line which permits proliferation of E1-deleted adeno-5 viruses, 21, 22 were cotransfected with 1 g pCA14-mFasL and 1 g pBHG10, an amount of DNA 10 times below that recommended by the producer. Interestingly, 1-2 days later the cells showed typical morphological features of death ( Figure 1a) . The same result was obtained upon transfection with 1 g pCA14-mFasL shuttle vector only (Figure 1b) . In a second series of experiments the adenovirus-5 system developed by He et al, 23 called AdEasy, was tested. The mFasL gene was first inserted into the pShuttle plasmid containing the human CMV promoter. Similarly to the previous experiment, transfection of 911 cells with 1 g pShuttle-mFasL resulted in cell death (Figure 1c) . The AdEasy vector system has been designed for recombination of shuttle vector (pShuttle) with adenovirus-5 plasmid backbone (pAdEasy-1) in E. coli instead of eukaryotic cells. In the experiment depicted in Figure 1d , 911 cells were transfected with 1 g linearized AdEasy-mFasL, the complete adenoviral sequence previously recombined in bacteria. In this case the cells showed only minimal signs of cytopathic effects after transfection. Gene Therapy DNA fragmentation in Figure 2 illustrates that the cause of cell death after transfection with pCA14-mFasL and pShuttle-mFasL is apoptosis. This is not surprising since the cells express the Fas receptor as demonstrated by FACS analyses (Figure 3a) and efficiently transcribe the FasL gene after transfection (Figure 3b) .
Adeno-5 mFasL viruses produced in 911 cells are supposed to infect various eukaryotic cells followed by the efficient expression of the mFasL gene. In order to demonstrate that, recombinant AdEasy-mFasL viruses were generated as described (titre: 10 9 /ml). The correct mFasL insert of the recombinant construct was proven by sequence analyses at the beginning and by PCR with mFasL-and adeno-5 virus-specific primers after each passage in 911 cells. Thereafter, COS cells were infected with AdEasy-mFasL viruses. They showed a positive mFasL band in RT-PCR with mFasL-specific primers (Figure 4) . mFasL molecules expressed on the membrane of AdEasy-mFasL-infected cells should be able to induce apoptosis of Fas-carrying cells. In the experiment depicted in Figure 5 COS cells were infected with AdEasy-mFasL viruses and thereafter coincubated with Jurkat cells, a human T cell line known to express Fas. One day after coculture the Jurkat cells died as a consequence of apoptosis.
In the article by Larregina et al 17 several approaches were proposed for the generation of recombinant adeno-5 viruses encoding for FasL. They include silencing of FasL expression by regulation of promoter activity during the development of the viral vectors in 293 cells, inhibition of FasL-induced apoptosis, or growing the virus on a novel cell line not expressing Fas which is stably transfected with the E1 region gene. We show here that the AdEasy vector system, which allows recombination of shuttle vector with adeno-5 virus backbone in bacteria, can be efficiently used for generation of recombinant adeno-5 mFasL viruses in 911 cells.
As shown in our experiments, 911 cells carry the Fas receptor. As a matter of fact, 2 days after transfection with 1 g pCA14-mFasL or pShuttle-mFasL the cells express mFasL and die from apoptosis. Our results clearly demonstrate that the human CMV promoter of both shuttle vectors is able to induce mFasL expression on the cell membrane efficiently. The question arises why most 911 cells transfected with recombined AdEasymFasL vector are still viable shortly after transfection and thus allow efficient virus production.
A major advantage of the AdEasy system as compared with the adenovirus-5 system of Graham's group is its recombination in bacteria which allows transfection of 911 cells with already recombined viral plasmids. Consequently, the entire 911 cell culture time is used exclusively for virus proliferation in 911 cells. This is a crucial factor for successful generation of mFasL geneharbouring viruses.
As shown by the RT-PCR data, the 911 cells do not express detectable amounts of mFasL in PCR early after AdEasy-mFasL transfection. This might be due to the smaller amount of adenoviral DNA, its bigger size, and its linearized form. Therefore, less linear AdEasy-mFasL DNA than circular shuttle plasmid DNA must have penetrated into the cells, and consequently, fewer mFasL molecules were expressed.
If the lower number of plasmid particles is the reason for less mFasL expression following AdEasy-mFasL transfection of 911 cells, one may ask the question whether reducing the amount of pCA14 and pBHG10 vector would lead to the same result. In order to obtain efficient recombination between the two vectors, how- Gene Therapy ever, the amount of plasmid DNA should not decrease below a certain limit. The DNA concentration we used was 10 times lower than that recommended by Hitt et al. 24 Even at that low concentration, pCA14 shuttle vector leads to high mFasL production and cell death.
In conclusion, the present work describes a method for efficient production of mFasL carrying adeno-5 viruses. This may be a general method for generating adeno-5 viruses carrying deleterious genes.
